Five-year, disease-free survival after repeat palliative multimodality therapy in a patient with recurrent metastatic bladder cancer.
In appropriately selected cases, palliative therapeutic strategies can be adapted to those special features of cancer biographies that indicate an atypical course of disease. Elucidating these features, and adapting multimodal treatment strategies to them, can lead to significantly superior effects when compared to the routine application of conventional treatment algorithms. A case of regionally metastatic bladder cancer is presented that documents the value of repeat debulking-surgery and repeat radiotherapy leading to unexpected short-term and long-term treatment results.
Fetscher
Sebastian
S
Division of Hematology and Oncology, Department of Internal Medicine, Sana Hospital Lübeck, Kronsforder Allee 72-74, D-23560 Lübeck, Germany. S.Fetscher@sana-luebeck.de
Schmielau
Jan
J
Schulze-Seemann
Wolfgang
W
D003131:Combined Modality Therapy; D018572:Disease-Free Survival; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D010166:Palliative Care; D012008:Recurrence; D013997:Time Factors; D001749:Urinary Bladder Neoplasms / Q000556:secondary* / Q000628:therapy*